Back to search results

Healthy Volunteer Study of D-2570

This study is looking for healthy volunteers aged 18 to 55 to test a drug called D-2570. You would receive either D-2570 or a placebo (an inactive substance, like a sugar pill). The main goals are to see how safe D-2570 is, how well your body tolerates it, and how your body processes it (pharmacokinetics). You cannot join if you have ongoing health issues, a history of drug or alcohol abuse, or are currently taking medications, including over-the-counter or herbal remedies. The study aims to enroll 36 participants, but its current status is unclear.

Study design
This is a double-blind study, meaning neither you nor the study staff will know if you are receiving D-2570 or the placebo. It is an interventional study, and it plans to enroll 36 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your safety will be monitored from when you give consent through the end of the study, which averages 48 days. Pharmacokinetic measurements will be taken from randomization through study completion, averaging 20 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07270783

Healthy Volunteer Study

Active, Not Recruiting
PHASE1Ages 18–55Interventional
InventisBio Co., Ltd
~36 participants
Updated 2026-07-14 on ClinicalTrials.gov
What's tested:D-2570Placebo

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Incidence of adverse events
Measured over From Informed Consent through study completion, an average of 48 days
+8 more outcomes measured

Conditions

Healthy Volunteer

Explore related trials

Healthy Volunteer

Where it's being run

1 sites across 1 states
Maryland1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Healthy volunteer subjects meeting eligibility criteria

Exclusion

Subjects with ongoing or history of disease or co-morbidities as assessed by Principal Investigator which would make them ineligible for the study
Subjects with a history of drug and alcohol abuse
Subjects taking medications, over the counter or herbal remedies

What this trial measures

  • Incidence of adverse eventsFrom Informed Consent through study completion, an average of 48 days

    Incidence of adverse events

  • Result of Pharmacokinetic endpointFrom Randomization through study completion, an average of 20 days

    Tmax

  • Result of Pharmacokinetic endpointFrom Randomization through study completion, an average of 20 days

    Cmax

  • Result of Pharmacokinetic endpointFrom Randomization through study completion, an average of 20 days

    t1/2

  • Result of Pharmacokinetic endpointFrom Randomization through study completion, an average of 20 days

    MRT

  • Result of Pharmacokinetic endpointFrom Randomization through study completion, an average of 20 days.

    AUC0-∞

  • Result of Pharmacokinetic endpointFrom Randomization through study completion, an average of 20 days

    AUC0-t

  • Result of Pharmacokinetic endpointFrom Randomization through study completion, an average of 20 days

    CL/F

  • Result of Pharmacokinetic endpointFrom Randomization through study completion, an average of 20 days

    Vz/F